EyePoint Pharmaceuticals, Inc. (EYPT)
USD 7.3
(2.38%)
USD 7.3
(2.38%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 41.38 Million USD | 25.12% |
| 2022 | 33.07 Million USD | 15.01% |
| 2021 | 28.76 Million USD | 0.52% |
| 2020 | 28.61 Million USD | 61.86% |
| 2019 | 17.67 Million USD | 213.75% |
| 2018 | -15.54 Million USD | -306.14% |
| 2017 | 7.53 Million USD | 836.52% |
| 2016 | 805 Thousand USD | -93.39% |
| 2015 | 12.18 Million USD | 258.88% |
| 2014 | 3.39 Million USD | 145.69% |
| 2013 | -7.43 Million USD | -113.57% |
| 2012 | -3.47 Million USD | -67.74% |
| 2011 | -2.07 Million USD | -109.0% |
| 2010 | 23.05 Million USD | 89.55% |
| 2009 | 12.16 Million USD | 249.88% |
| 2008 | 3.47 Million USD | 55.53% |
| 2007 | 2.23 Million USD | 52.52% |
| 2006 | 1.46 Million USD | 132.78% |
| 2005 | 629.52 Thousand USD | 137.35% |
| 2004 | 265.22 Thousand USD | 256.73% |
| 2003 | 74.35 Thousand USD | -85.6% |
| 2002 | 516.32 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 8.07 Million USD | -26.08% |
| 2024 Q1 | 10.92 Million USD | -16.16% |
| 2023 FY | 41.38 Million USD | 25.12% |
| 2023 Q3 | 14 Million USD | 91.44% |
| 2023 Q4 | 13.03 Million USD | -6.93% |
| 2023 Q1 | 7.04 Million USD | -1.12% |
| 2023 Q2 | 7.31 Million USD | 3.83% |
| 2022 Q2 | 9.83 Million USD | 30.78% |
| 2022 Q3 | 8.6 Million USD | -12.45% |
| 2022 Q4 | 7.12 Million USD | -17.24% |
| 2022 Q1 | 7.51 Million USD | -11.68% |
| 2022 FY | 33.07 Million USD | 15.01% |
| 2021 Q4 | 8.51 Million USD | 17.65% |
| 2021 Q3 | 7.23 Million USD | 2.12% |
| 2021 FY | 28.76 Million USD | 0.52% |
| 2021 Q1 | 5.93 Million USD | 27.04% |
| 2021 Q2 | 7.08 Million USD | 19.4% |
| 2020 Q3 | 13.81 Million USD | 281.57% |
| 2020 Q2 | 3.62 Million USD | -44.38% |
| 2020 FY | 28.61 Million USD | 61.86% |
| 2020 Q4 | 4.67 Million USD | -66.19% |
| 2020 Q1 | 6.5 Million USD | -10.95% |
| 2019 Q4 | 7.3 Million USD | 234.97% |
| 2019 Q1 | 1.68 Million USD | 196.83% |
| 2019 Q2 | 6.5 Million USD | 286.68% |
| 2019 Q3 | 2.18 Million USD | -66.45% |
| 2019 FY | 17.67 Million USD | 213.75% |
| 2018 Q2 | -4.05 Million USD | -68.96% |
| 2018 Q4 | -1.73 Million USD | 69.78% |
| 2018 FY | -15.54 Million USD | -306.14% |
| 2018 Q1 | -2.39 Million USD | 28.15% |
| 2018 Q3 | -5.74 Million USD | -41.9% |
| 2017 Q3 | 385 Thousand USD | -45.08% |
| 2017 FY | 7.53 Million USD | 836.52% |
| 2017 Q1 | -2.73 Million USD | -197.43% |
| 2017 Q2 | 701 Thousand USD | 125.64% |
| 2017 Q4 | -3.33 Million USD | -966.49% |
| 2016 FY | 805 Thousand USD | -93.39% |
| 2016 Q4 | 2.8 Million USD | 180.98% |
| 2016 Q2 | -3.8 Million USD | -38.18% |
| 2016 Q3 | -3.46 Million USD | 8.82% |
| 2016 Q1 | -2.75 Million USD | 13.93% |
| 2015 Q1 | -3.01 Million USD | -34.06% |
| 2015 Q3 | -3.01 Million USD | -8.14% |
| 2015 FY | 12.18 Million USD | 258.88% |
| 2015 Q2 | -2.78 Million USD | 7.37% |
| 2015 Q4 | -3.19 Million USD | -5.94% |
| 2014 Q4 | -2.24 Million USD | -109.97% |
| 2014 Q3 | 22.52 Million USD | 10424.77% |
| 2014 Q2 | 214 Thousand USD | -89.24% |
| 2014 FY | 3.39 Million USD | 145.69% |
| 2014 Q1 | 1.98 Million USD | 204.52% |
| 2013 Q1 | -1.07 Million USD | -8.48% |
| 2013 Q4 | -1.9 Million USD | 0.26% |
| 2013 FY | -7.43 Million USD | -113.57% |
| 2013 Q3 | -1.9 Million USD | -4.32% |
| 2013 Q2 | -1.82 Million USD | -70.2% |
| 2012 Q3 | -970 Thousand USD | -36.43% |
| 2012 Q4 | -990 Thousand USD | -2.06% |
| 2012 Q2 | -711 Thousand USD | 26.7% |
| 2012 Q1 | -970 Thousand USD | -253.97% |
| 2012 FY | -3.47 Million USD | -67.74% |
| 2011 Q2 | 3.71 Million USD | 931.94% |
| 2011 Q3 | 1.65 Million USD | -55.34% |
| 2011 FY | -2.07 Million USD | -109.0% |
| 2011 Q4 | 630 Thousand USD | -62.03% |
| 2011 Q1 | 360 Thousand USD | -13.04% |
| 2010 Q4 | 414 Thousand USD | -13.03% |
| 2010 Q3 | 476 Thousand USD | -96.97% |
| 2010 Q2 | 15.72 Million USD | 2952.82% |
| 2010 FY | 23.05 Million USD | 89.55% |
| 2010 Q1 | 515 Thousand USD | -85.0% |
| 2009 FY | 12.16 Million USD | 249.88% |
| 2009 Q1 | 3.16 Million USD | 6.5% |
| 2009 Q2 | 995 Thousand USD | -68.54% |
| 2009 Q3 | 3.38 Million USD | 240.0% |
| 2009 Q4 | 3.43 Million USD | 1.48% |
| 2008 FY | 3.47 Million USD | 55.53% |
| 2008 Q1 | 542 Thousand USD | 323.44% |
| 2008 Q4 | 2.97 Million USD | 413.84% |
| 2008 Q3 | 578 Thousand USD | -78.58% |
| 2008 Q2 | 2.69 Million USD | 397.79% |
| 2007 Q3 | -3.36 Million USD | -840.22% |
| 2007 Q4 | 128 Thousand USD | 103.8% |
| 2007 FY | 2.23 Million USD | 52.52% |
| 2007 Q1 | 65 Thousand USD | -92.24% |
| 2007 Q2 | 455 Thousand USD | 600.0% |
| 2006 Q3 | 790.44 Thousand USD | 92.92% |
| 2006 Q4 | 837.18 Thousand USD | 5.91% |
| 2006 FY | 1.46 Million USD | 132.78% |
| 2006 Q1 | 351.9 Thousand USD | -47.53% |
| 2006 Q2 | 409.71 Thousand USD | 16.43% |
| 2005 Q1 | 160.36 Thousand USD | -0.9% |
| 2005 Q3 | 375.12 Thousand USD | 152.73% |
| 2005 Q4 | 670.7 Thousand USD | 78.8% |
| 2005 Q2 | 148.42 Thousand USD | -7.44% |
| 2005 FY | 629.52 Thousand USD | 137.35% |
| 2004 FY | 265.22 Thousand USD | 256.73% |
| 2004 Q4 | 161.81 Thousand USD | 7.34% |
| 2004 Q1 | 72.86 Thousand USD | 1.49% |
| 2004 Q2 | 46.64 Thousand USD | -35.99% |
| 2004 Q3 | 150.74 Thousand USD | 223.21% |
| 2003 Q1 | 16.72 Thousand USD | 7.78% |
| 2003 Q3 | 64.89 Thousand USD | 168.55% |
| 2003 Q4 | 71.79 Thousand USD | 10.63% |
| 2003 FY | 74.35 Thousand USD | -85.6% |
| 2003 Q2 | 24.16 Thousand USD | 44.45% |
| 2002 Q3 | 15.02 Thousand USD | 0.0% |
| 2002 FY | 516.32 Thousand USD | 0.0% |
| 2002 Q4 | 15.52 Thousand USD | 3.31% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 191.309% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 138.998% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -96.505% |
| Autolus Therapeutics plc | -4.86 Million USD | 950.339% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 1145891.805% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 5056.407% |
| Shattuck Labs, Inc. | -2.38 Million USD | 1835.262% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 1819.402% |
| CervoMed Inc. | -1.29 Million USD | 3299.222% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 683.066% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 232.785% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 8821.196% |
| Precision BioSciences, Inc. | 40.47 Million USD | -2.258% |
| Dyadic International, Inc. | 922.95 Thousand USD | -4384.066% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 161.674% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 28253.741% |
| Nektar Therapeutics | 53.47 Million USD | 22.611% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 58.212% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -9660.849% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 9792.272% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 56.308% |
| GRI Bio, Inc. | 10.84 Million USD | -281.754% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -1529.379% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 576.413% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 42765.979% |
| Psyence Biomedical Ltd. | -240.00 USD | 17244266.667% |
| IGM Biosciences, Inc. | -211.66 Million USD | 119.553% |
| INmune Bio, Inc. | 155 Thousand USD | -26600.645% |
| Opthea Limited | 21.72 Thousand USD | -190443.278% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -10195.025% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 165.928% |
| Verastem, Inc. | -62 Thousand USD | 66851.613% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -1599.63% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 15956.705% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1267.228% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 65.441% |
| NextCure, Inc. | -3.68 Million USD | 1223.398% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 409.825% |
| Organovo Holdings, Inc. | -5.38 Million USD | 867.972% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 71.8 Million USD | 42.359% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 3534.865% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -106.393% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 5134.793% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -582.214% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 73.263% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 142.137% |
| Senti Biosciences, Inc. | -2.68 Million USD | 1642.527% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -28285.46% |
| Apollomics, Inc. | 127 Thousand USD | -32487.402% |
| PureTech Health plc | -1.6 Million USD | 2681.784% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 242.868% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -5060.349% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 137.457% |
| Synaptogenix, Inc. | -6347.00 USD | 652156.089% |
| ChromaDex Corporation | 50.78 Million USD | 18.499% |
| Beam Therapeutics Inc. | -59.67 Million USD | 169.356% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 65.647% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 136.899% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 87.759% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 761.118% |
| Mesoblast Limited | -9.81 Million USD | 521.661% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 69.405% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 142.16% |
| MediWound Ltd. | 3.57 Million USD | -1056.68% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -34388.333% |
| Fortress Biotech, Inc. | 57.85 Million USD | 28.464% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -96146.512% |
| Achilles Therapeutics plc | -4.73 Million USD | 974.734% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 67.055% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 195.221% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 180039.13% |
| Zai Lab Limited | 170.9 Million USD | 75.784% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -416.937% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -31735.385% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 76.729% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -161.045% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.592% |
| FibroGen, Inc. | 128.9 Million USD | 67.894% |
| Celcuity Inc. | -142.77 Thousand USD | 29087.477% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| ContextLogic Inc. | 59 Million USD | 29.854% |
| GH Research PLC | -315 Thousand USD | 13238.413% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -149.659% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -10539.075% |
| ImmuCell Corporation | 4.39 Million USD | -841.386% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 88.353% |
| Amarin Corporation plc | 165.54 Million USD | 75.0% |
| TG Therapeutics, Inc. | 219.1 Million USD | 81.112% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 7399.118% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 3835.199% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 154.791% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 43.618% |
| Aptorum Group Limited | -1.11 Million USD | 3812.788% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 89.362% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 87.334% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 62030.058% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 82.808% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 8108.964% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1265.475% |
| Ardelyx, Inc. | 106.66 Million USD | 61.199% |
| Ainos, Inc. | -253.73 Thousand USD | 16410.846% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 189.058% |
| Prothena Corporation plc | -129.2 Million USD | 132.032% |
| HilleVax, Inc. | -2.15 Million USD | 2019.573% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 17.924% |
| Celularity Inc. | 6.75 Million USD | -512.672% |
| Rallybio Corporation | -150 Thousand USD | 27690.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 226.924% |
| Omeros Corporation | -69.77 Million USD | 159.31% |
| Humacyte, Inc. | -76.55 Million USD | 154.064% |
| Immunocore Holdings plc | 248.39 Million USD | 83.338% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 372.833% |
| Blueprint Medicines Corporation | 236.58 Million USD | 82.507% |
| IO Biotech, Inc. | -756 Thousand USD | 5574.339% |
| MEI Pharma, Inc. | 49.32 Million USD | 16.099% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 3002.244% |
| Summit Therapeutics Inc. | -2.05 Million USD | 2118.829% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 962.568% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -42.44% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1555.204% |
| Pulmatrix, Inc. | -8.22 Million USD | 603.479% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 3637.265% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 2173.447% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 10472.431% |
| Acelyrin, Inc. | -115 Thousand USD | 36087.826% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 110.378% |
| Cytokinetics, Incorporated | -322.59 Million USD | 112.829% |
| Vor Biopharma Inc. | -3.49 Million USD | 1285.166% |
| Evogene Ltd. | 1.39 Million USD | -2858.256% |
| Replimune Group, Inc. | -2.65 Million USD | 1658.795% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 194.248% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 72294.118% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -503.558% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -3635.199% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 125512.121% |
| Atai Life Sciences N.V. | -5000.00 USD | 827820.0% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 43210.417% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -8243.952% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 3079.554% |
| Sagimet Biosciences Inc. | 2 Million USD | -1969.3% |
| MediciNova, Inc. | 979.7 Thousand USD | -4124.333% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 149.083% |
| MiMedx Group, Inc. | 266.84 Million USD | 84.491% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 43869.235% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 83.076% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 95.256% |
| Mereo BioPharma Group plc | 7.42 Million USD | -457.312% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 344983.333% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 827820.0% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 1781.674% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 773.929% |
| scPharmaceuticals Inc. | 9.78 Million USD | -323.083% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 159.983% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 91.304% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 362880.505% |
| Precigen, Inc. | 106 Thousand USD | -38943.396% |
| XOMA Corporation | 3.86 Million USD | -971.898% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 159.051% |
| Incyte Corporation | 3.44 Billion USD | 98.797% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 81664.84% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -179.749% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -232.151% |
| Seer, Inc. | 7.02 Million USD | -488.957% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 82.824% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 142810.345% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -318353746.154% |
| Akari Therapeutics, Plc | -4000.00 USD | 1034750.0% |
| Novavax, Inc. | 639.93 Million USD | 93.533% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -21155.418% |
| UroGen Pharma Ltd. | 73.35 Million USD | 43.579% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 255.039% |
| Entera Bio Ltd. | -56 Thousand USD | 74003.571% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 21997.354% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -921.624% |
| Chimerix, Inc. | 324 Thousand USD | -12673.457% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 7983.048% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -7936.117% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 93758.912% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.782% |
| AnaptysBio, Inc. | 14.78 Million USD | -179.995% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -7082.837% |
| Portage Biotech Inc. | -54 Thousand USD | 76740.741% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 11077.719% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 3392.442% |
| OKYO Pharma Limited | -7506.16 USD | 551460.483% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 920811.902% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 2090302.02% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 18642442.342% |
| AbCellera Biologics Inc. | 38.02 Million USD | -8.839% |
| Genprex, Inc. | -15 Thousand USD | 275933.111% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 6295.509% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 362880.505% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 2.76 Million USD | -1394.337% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 2493.638% |
| Bicycle Therapeutics plc | -129.52 Million USD | 131.953% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 110.355% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 26.993% |
| Erasca, Inc. | -3.73 Million USD | 1208.95% |
| bluebird bio, Inc. | -4.03 Million USD | 1126.948% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -4001.685% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 97.827% |
| DBV Technologies S.A. | 15.72 Million USD | -163.136% |
| Fortress Biotech, Inc. | 57.85 Million USD | 28.464% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 122.814% |
| CorMedix Inc. | -205.56 Thousand USD | 20233.099% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 69.066% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 7347.986% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1507.848% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 205.193% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 137.242% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -69.261% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1253.456% |
| Onconetix, Inc. | -1.12 Million USD | 3771.69% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -117.329% |
| Prime Medicine, Inc. | -147.9 Million USD | 127.981% |
| Adagene Inc. | 18.11 Million USD | -128.507% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -6695.731% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 28980.468% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 70.481% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 123.897% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 73.779% |
| SciSparc Ltd. | 2.19 Million USD | -1784.608% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 165320.168% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 133680.789% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 57.054% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 24.228% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 682.437% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 97.273% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 57.893% |
| ADMA Biologics, Inc. | 88.21 Million USD | 53.087% |
| Clene Inc. | 533 Thousand USD | -7664.728% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -71.661% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 4424.556% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -1981.791% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 21398.298% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 16.904% |
| Absci Corporation | -41.84 Million USD | 198.894% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.634% |
| Surrozen, Inc. | -27.23 Million USD | 251.987% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 153.334% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 188.358% |
| Cingulate Inc. | -582.91 Thousand USD | 7199.798% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 133603.226% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 546810.7% |
| Jaguar Health, Inc. | 7.72 Million USD | -435.81% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 4797.616% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 93.92% |
| Kronos Bio, Inc. | 1.37 Million USD | -2916.472% |
| Innoviva, Inc. | 261.06 Million USD | 84.147% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 177.118% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -42.078% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 398042.308% |
| Soligenix, Inc. | 97.31 Thousand USD | -42429.622% |
| AlloVir, Inc. | -398 Thousand USD | 10498.492% |
| Century Therapeutics, Inc. | -10.8 Million USD | 482.885% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 4110.271% |
| Kura Oncology, Inc. | -849 Thousand USD | 4974.676% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 24734.524% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 33.183% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 2847.543% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 6482.257% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 141474.599% |
| HCW Biologics Inc. | -574.82 Thousand USD | 7299.769% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 142.688% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 13322.364% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 56.187% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 23770.379% |
| Histogen Inc. | 3.76 Million USD | -998.063% |
| Surrozen, Inc. | -27.23 Million USD | 251.987% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 11165.775% |
| Kodiak Sciences Inc. | -25.94 Million USD | 259.502% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 314631.084% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 61749.61% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 2124.755% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -6366.563% |
| Moderna, Inc. | 2.15 Billion USD | 98.08% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 94.684% |
| Turnstone Biologics Corp. | 16.5 Million USD | -150.733% |
| Immix Biopharma, Inc. | -5468.00 USD | 756976.372% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 81249.02% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 74.353% |
| Exelixis, Inc. | 1.75 Billion USD | 97.645% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 765.156% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 60.244% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 96.989% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 3835.199% |
| Arcellx, Inc. | 108.27 Million USD | 61.778% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 35027.547% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -465.537% |
| Insmed Incorporated | 239.63 Million USD | 82.73% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 227.857% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 47.748% |
| Moolec Science SA | -143.3 Thousand USD | 28979.662% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 197.798% |
| Geron Corporation | -123.5 Million USD | 133.51% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1159.081% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -845.317% |
| Royalty Pharma plc | 1.79 Billion USD | 97.693% |
| OmniAb, Inc. | 14.66 Million USD | -182.171% |
| Alector, Inc. | -95.05 Million USD | 143.54% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 159.047% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 137.146% |
| Humacyte, Inc. | -76.55 Million USD | 154.064% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 4460.212% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 49.453% |
| 89bio, Inc. | -273 Thousand USD | 15259.707% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | -1.29 Million USD | 3295.83% |
| Immunic, Inc. | -111 Thousand USD | 37384.685% |
| Veracyte, Inc. | 248.14 Million USD | 83.322% |
| Genelux Corporation | -848 Thousand USD | 4980.425% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 33747.154% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 7338043.262% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 454.731% |
| Immunovant, Inc. | -231 Thousand USD | 18016.017% |
| Vericel Corporation | 135.57 Million USD | 69.474% |
| Fortrea Holdings Inc. | 424 Million USD | 90.239% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 148.03% |
| XBiotech Inc. | -1.74 Million USD | 2473.05% |
| Agenus Inc. | 139.61 Million USD | 70.357% |
| Acasti Pharma Inc. | -11 Thousand USD | 376336.364% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1127.703% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 20326.081% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 6482.257% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -146.301% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 183.361% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 465.477% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 10962.467% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 288.229% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 39.251% |
| United Therapeutics Corporation | 2.07 Billion USD | 98.001% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -766307.407% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 50214.43% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -62356.236% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1149.86% |
| Pharming Group N.V. | 220.1 Million USD | 81.197% |
| XOMA Corporation | 3.86 Million USD | -971.898% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 9626.089% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 3953.445% |
| Pyxis Oncology, Inc. | -2 Million USD | 2169.3% |
| uniQure N.V. | 2.21 Million USD | -1768.442% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 2278.211% |
| Cassava Sciences, Inc. | -89.42 Million USD | 146.281% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 18828.646% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 50570.732% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 144.951% |
| Pluri Inc. | 322 Thousand USD | -12752.795% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 287 Thousand USD | -14320.209% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 33.657% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 496.229% |
| CalciMedica, Inc. | -58 Thousand USD | 71455.172% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 234.087% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 88.568% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 411860.024% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 3953.445% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -1391.073% |
| Nutriband Inc. | 862.1 Thousand USD | -4700.575% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 12236.657% |
| Compugen Ltd. | 31.45 Million USD | -31.572% |
| Roivant Sciences Ltd. | 109.23 Million USD | 62.113% |
| ProKidney Corp. | -3.16 Million USD | 1405.964% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 146765.249% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -3547.693% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 152.606% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 34062.202% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -68.812% |
| Benitec Biopharma Inc. | 108 Thousand USD | -38220.37% |
| GeoVax Labs, Inc. | -20.72 Million USD | 299.732% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1085.146% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 13450.323% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 154.189% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 80.637% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 280.749% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 53158.974% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 4498.087% |
| Imunon, Inc. | -720 Thousand USD | 5848.016% |
| BioAtla, Inc. | -103.73 Million USD | 139.897% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 117.044% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 13407.395% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | -2.38 Million USD | 1833.082% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 7953.131% |
| Viridian Therapeutics, Inc. | -1 Million USD | 4205.754% |
| Galecto, Inc. | -830 Thousand USD | 5086.265% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 93.502% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -3598.481% |
| PolyPid Ltd. | -1.82 Million USD | 2371.46% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 34878.151% |
| Forte Biosciences, Inc. | -9000.00 USD | 459944.444% |
| Xencor, Inc. | -85.26 Million USD | 148.541% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 4233.491% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -21155.418% |
| Instil Bio, Inc. | -4.75 Million USD | 970.185% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 43869.235% |
| OncoCyte Corporation | 413 Thousand USD | -9920.823% |
| Elevation Oncology, Inc. | -39 Thousand USD | 106217.949% |
| Purple Biotech Ltd. | -196 Thousand USD | 21215.306% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -361.485% |
| MacroGenics, Inc. | 50.52 Million USD | 18.091% |
| Verona Pharma plc | -679.62 Thousand USD | 6189.544% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 23749.143% |
| Aditxt, Inc. | -111.66 Thousand USD | 37164.302% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | -44.26 Million USD | 193.502% |
| Curis, Inc. | 9.81 Million USD | -321.833% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 33265.048% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 18251.754% |
| BeiGene, Ltd. | 2.07 Billion USD | 98.009% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 146765.249% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 4623.06% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 966.36% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 7821.269% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 62.298% |
| Adicet Bio, Inc. | -6.09 Million USD | 778.682% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -8380.738% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | -73.91 Million USD | 155.994% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 9570.481% |
| Invivyd, Inc. | -2.02 Million USD | 2140.73% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 113.757% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 40110.441% |
| Moolec Science SA | -143.3 Thousand USD | 28979.662% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -425.804% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 827820.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 5050.478% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 50.385% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -56506.303% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 22.151% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 11824.079% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 310.092% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 4288.866% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 73554.971% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -92.091% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 86.806% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 14273.288% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 6332.831% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -931.298% |
| ImmunityBio, Inc. | -17.89 Million USD | 331.336% |
| Korro Bio, Inc. | -3.63 Million USD | 1240.11% |
| Kineta, Inc. | 5.43 Million USD | -661.752% |
| BioVie Inc. | -229.37 Thousand USD | 18142.785% |
| Codexis, Inc. | 57.33 Million USD | 27.816% |
| Celularity Inc. | 6.75 Million USD | -512.672% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -81706.681% |
| Cibus, Inc. | 1.42 Million USD | -2810.408% |
| Annexon, Inc. | -3.26 Million USD | 1366.789% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 199.159% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 76.071% |
| NeurAxis, Inc. | 2.15 Million USD | -1818.947% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 295.66% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 2289.735% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -17785.743% |
| Notable Labs, Ltd. | 113 Thousand USD | -36524.779% |
| IN8bio, Inc. | -2.5 Million USD | 1754.778% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 138053.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -2122.664% |
| Lumos Pharma, Inc. | 2 Million USD | -1962.083% |
| Liquidia Corporation | 14.6 Million USD | -183.466% |
| Mustang Bio, Inc. | -2.22 Million USD | 1960.045% |
| Quantum-Si incorporated | 488 Thousand USD | -8380.738% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 174.49% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 23749.143% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 306.558% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 39263.473% |
| Vaxcyte, Inc. | -75 Million USD | 155.181% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 124.706% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 3540.233% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -30.725% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 2213.687% |
| PepGen Inc. | -1.18 Million USD | 3595.439% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 32687.402% |
| Solid Biosciences Inc. | -76.56 Million USD | 154.055% |
| Palisade Bio, Inc. | 246 Thousand USD | -16723.577% |
| Nutriband Inc. | 862.1 Thousand USD | -4700.575% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 5516.037% |
| Belite Bio, Inc | -399 Thousand USD | 10472.431% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 190.862% |
| GeoVax Labs, Inc. | -20.72 Million USD | 299.732% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 125512.121% |
| Altimmune, Inc. | -65.37 Million USD | 163.307% |
| Peak Bio, Inc. | 367.76 Thousand USD | -11153.26% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 9570.481% |
| Neurogene Inc. | -3.26 Million USD | 1368.731% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 70.297% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 75347.273% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1220.964% |
| Sesen Bio, Inc. | 40 Million USD | -3.465% |
| argenx SE | 1.1 Billion USD | 96.266% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 3540.233% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -1574.868% |
| Immunome, Inc. | -8.9 Million USD | 564.646% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 10242.882% |
| Design Therapeutics, Inc. | -537 Thousand USD | 7806.89% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -1828.518% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 14034.68% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 532.636% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -193.935% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 1649.151% |
| Athira Pharma, Inc. | -969 Thousand USD | 4371.001% |
| XOMA Corporation | 3.86 Million USD | -971.898% |
| Merus N.V. | -83.46 Million USD | 149.587% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 12952.795% |
| Rezolute, Inc. | -36 Thousand USD | 115061.111% |
| Clene Inc. | 533 Thousand USD | -7664.728% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 3223308.723% |
| BeyondSpring Inc. | 1.75 Million USD | -2263.564% |
| Synlogic, Inc. | -1.92 Million USD | 2251.04% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 111954.054% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 753.601% |
| Peak Bio, Inc. | 367.76 Thousand USD | -11153.26% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 318.246% |
| Krystal Biotech, Inc. | 47.6 Million USD | 13.064% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 70.667% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -723.602% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 1698.397% |
| MannKind Corporation | 136.19 Million USD | 69.612% |
| Ikena Oncology, Inc. | -50.49 Million USD | 181.965% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 61.966% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1043.808% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 16523.016% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 827820.0% |
| Legend Biotech Corporation | 140.92 Million USD | 70.633% |
| Mural Oncology plc | -2.56 Million USD | 1712.232% |
| Disc Medicine, Inc. | -100 Thousand USD | 41486.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -99.412% |
| REGENXBIO Inc. | 53.02 Million USD | 21.956% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 872.566% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 21613.19% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 2489.492% |
| Vaxart, Inc. | -60.76 Million USD | 168.111% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 15849.296% |
| Cellectis S.A. | 18 Thousand USD | -229822.222% |
| Longeveron Inc. | 221 Thousand USD | -18626.697% |
| Repare Therapeutics Inc. | -80.07 Million USD | 151.687% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 96.214% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 3298.3% |
| Revolution Medicines, Inc. | -399.66 Million USD | 110.355% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 118345.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -84361.224% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.519% |
| Denali Therapeutics Inc. | -93.34 Million USD | 144.337% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 165320.168% |
| Veru Inc. | 7.56 Million USD | -447.005% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 27507.947% |
| Cingulate Inc. | -582.91 Thousand USD | 7199.798% |
| Passage Bio, Inc. | -3.72 Million USD | 1212.228% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 343723.381% |
| Exicure, Inc. | -1.42 Million USD | 3008.363% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 10905.744% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -1431.114% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 8172.561% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 27763.144% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 169.902% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -10484.655% |
| OmniAb, Inc. | 14.66 Million USD | -182.171% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -107.002% |
| Lipocine Inc. | -2.85 Million USD | 1551.724% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 2345.578% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 825.434% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 2847.543% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 45.05% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 63770.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 50.904% |
| Ocugen, Inc. | -33.53 Million USD | 223.404% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1408.855% |
| Q32 Bio Inc. | 578 Thousand USD | -7060.208% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 15717.358% |
| Alumis Inc. Common Stock | -1.28 Million USD | 3323.209% |
| Equillium, Inc. | 35.95 Million USD | -15.095% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 2524.487% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -8165.975% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1001212.724% |
| Dominari Holdings Inc. | 2.03 Million USD | -1929.72% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 22657.243% |
| vTv Therapeutics Inc. | -13.59 Million USD | 404.421% |
| Bio-Techne Corporation | 773.07 Million USD | 94.647% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -138.963% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 91.018% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 3640.291% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 272.585% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -253.817% |
| Nkarta, Inc. | -5.86 Million USD | 805.163% |
| BioCardia, Inc. | -7.24 Million USD | 670.92% |
| Iterum Therapeutics plc | -1.75 Million USD | 2464.914% |